登录 | 注册    关注公众号  
微信公众号
搜索
 >  Kits>CTLA-4 >EP-126

CTLA-4 [Biotinylated] : B7-2 Inhibitor Screening ELISA Kit

For research use only.

IDComponentsSize
EP126-C01High-bind Plate1 plate
EP126-C02Human B7-220 μg
EP126-C03Biotinylated Human CTLA-410 μg
EP126-C04Anti-CTLA-4 Neutralizing Antibody20 μg
EP126-C05Streptavidin-HRP10 μg
EP126-C06Coating Buffer12 mL
EP126-C0710xWashing Buffer 50 mL
EP126-C08Blocking Buffer50 mL
EP126-C09Substrate Solution12 mL
EP126-C10Stop Solution7 mL

背景(Background)

Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.

应用说明(Application)

This kit is developed for screening for inhibitors of human CTLA-4 binding to human B7-2

It is for research use only.

重构方法(Reconstitution)

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage)

Unopened kit should be stored at 2°C -8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

原理(Assay Principles)

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new CTLA-4 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human CTLA-4 to immobilized human B7-2 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinlated CTLA-4 protein, a human B7-2 protein, an anti-CTLA-4 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human B7-2.

b) Add your molecule of interest to the tests.

c) Add human CTLA-4-Biotin to bind the coated human B7-2.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the half maximal inhibitory concentration (IC50) of your compound to CTLA-4: B7-2 binding will be determined by comparing OD readings among different experimental groups.

 

典型数据-Typical Data Please refer to DS document for The assay protocol.

CTLA-4 TYPICAL DATA

INHIBITION OF CTLA-4 [BIOTINYLATED]: B7-2 BINDING BY ANTI-CTLA-4 NEUTRALIZING ANTIBODY
Serial dilutions of Anti-CTLA-4 Neutralizing antibody (Catalog # EP126-C04) (1:1 serial dilution, from 10 μg/mL to 0.02μg/mL) was added into B7-2: Biotinlated CTLA-4 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

 

前沿进展

 
 
货号/价格
文档
联系电话:
+86 400-682-2521(全国)
010-53681107(北京)
021-50850665(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CTLA-4靶点信息
英文全称:Cytotoxic T-Lymphocyte-Associated Antigen 4
中文全称:细胞毒性T淋巴细胞相关抗原4
种类:Homo sapiens
上市药物数量:3详情
临床药物数量:57详情
最高研发阶段:批准上市
查看更多信息
前沿进展
点击查看详细
相关产品
View All CTLA-4

消息提示

请输入您的联系方式,再点击提交!

确定